申请人:Chen Xinghai
公开号:US20140073793A1
公开(公告)日:2014-03-13
The present invention discloses: (i) the novel germanium-containing camptothecin compound, 7[2′-trimethylgermanyl]ethyl-20(S) camptothecin, and pharmaceutically-acceptable salts thereof; (ii) methods of synthesis of said novel germanium-containing camptothecin compound, 7[2′-trimethylgermanyl]ethyl-20(S) camptothecin, and pharmaceutically-acceptable salts; (iii) pharmaceutically-acceptable formulations comprising said novel germanium-containing camptothecin compound, 7[2′-trimethylgermanyl]ethyl-20(S) camptothecin, and pharmaceutically-acceptable salts thereof; and (iv) methods of administration of said novel germanium-containing camptothecin compound, 7[2′-trimethylgermanyl]ethyl-20(S) camptothecin, and pharmaceutically-acceptable salts thereof to subjects in need thereof, including subjects with cancer.
本发明公开了:(i) 新型含锗紫杉醇化合物,7[2'-三甲基锗基]乙基-20(S)紫杉醇,及其药用盐;(ii) 所述新型含锗紫杉醇化合物,7[2'-三甲基锗基]乙基-20(S)紫杉醇及其药用盐的合成方法;(iii) 包括所述新型含锗紫杉醇化合物,7[2'-三甲基锗基]乙基-20(S)紫杉醇及其药用盐的药用配方;以及(iv) 将所述新型含锗紫杉醇化合物,7[2'-三甲基锗基]乙基-20(S)紫杉醇及其药用盐用于需要的受试者的给药方法,包括癌症患者。